| Name | Title | Contact Details |
|---|
Kaleido Biosciences is a clinical-stage biotechnology company engaged in the development of novel chemistries that unlock the power of the microbiome to revolutionize health. The Company has built the first R&D engine to systematically create, discover, and develop interventions that activate metabolic processes in the microbiome to treat disease and maintain health. Since its founding in 2015 by Flagship VentureLabs, Kaleido has advanced candidate products into clinical studies across programs in rare genetic diseases, oncology and infectious disease, and has generated more than 3,000 days of human clinical data. The Company is also creating consumer products that optimize the microbiome`s natural roles in promoting health.
Madison Radiology Medical Group is a Pasadena, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Synertech Inc is a Philadelphia, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Fujirebio Diagnostics, Inc. (FDI) is a Malvern, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Diagnostic Hybrids, Inc. is a Athens, OH-based company in the Healthcare, Pharmaceuticals, and Biotech sector.